Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><electronic-resource-num>10.1200\/jco.2012.44.8738<\/electronic-resource-num><urls><related-urls><url>https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2012.44.8738?role=tab<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1016\/j.expneurol.2007.11.001<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/2323600<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Acetyl-l-carnitine deficiency in patients with major depressive disorder.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1073\/pnas.1801609115<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.pnas.org\/content\/pnas\/115\/34\/8627.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2006<\/year><\/dates><electronic-resource-num>10.1016\/j.neulet.2005.12.013<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/1805703<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Ferreira GC<\/author><author>McKenna MC<\/author><\/authors><\/contributors><titles><title>L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.<\/title><secondary-title>Neurochemical research<\/secondary-title><\/titles><dates><year>2017<\/year><\/dates><electronic-resource-num>10.1007\/s11064-017-2288-7<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2002<\/year><\/dates><electronic-resource-num>10.1073\/pnas.261708898<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/122286<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1998<\/year><\/dates><electronic-resource-num>10.1073\/pnas.95.16.9562<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/21378<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2005<\/year><\/dates><electronic-resource-num>10.2337\/diacare.28.1.89<\/electronic-resource-num><urls><related-urls><url>https:\/\/diabetesjournals.org\/care\/article-pdf\/28\/1\/89\/646192\/zdc00105000089.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2004<\/year><\/dates><electronic-resource-num>10.1196\/annals.1320.003<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1016\/j.pain.2007.06.001<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/2689385<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Long-term acetyl-L-carnitine treatment in Alzheimer's disease.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1991<\/year><\/dates><electronic-resource-num>10.1212\/wnl.41.11.1726<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2003<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2003<\/year><\/dates><electronic-resource-num>10.1097\/00004850-200303000-00001<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2005<\/year><\/dates><electronic-resource-num>10.1016\/j.ejca.2005.04.028<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Involvement of PI3K\/PKG\/ERK1\/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2007<\/year><\/dates><electronic-resource-num>10.1016\/j.freeradbiomed.2006.11.006<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/1808543<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Zanelli SA<\/author><author>Solenski NJ<\/author><author>Rosenthal RE et al.<\/author><\/authors><\/contributors><titles><title>Mechanisms of ischemic neuroprotection by acetyl-L-carnitine.<\/title><secondary-title>Annals of the New York Academy of Sciences<\/secondary-title><\/titles><dates><year>2005<\/year><\/dates><electronic-resource-num>10.1196\/annals.1344.013<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fangfang Liu<\/author><author>Jingyu Chen<\/author><author>Kai Li et al.<\/author><\/authors><\/contributors><titles><title>Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches<\/title><secondary-title>Molecular Cancer<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1186\/s12943-024-02046-3<\/electronic-resource-num><urls><related-urls><url>https:\/\/molecular-cancer.biomedcentral.com\/counter\/pdf\/10.1186\/s12943-024-02046-3<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Acetyl-L-carnitine and \u03b1-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.1016\/j.pbb.2011.09.002<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Mary\u2010Elizabeth Patti<\/author><author>Silvia Corvera<\/author><\/authors><\/contributors><titles><title>The Role of Mitochondria in the Pathogenesis of Type 2 Diabetes<\/title><secondary-title>Endocrine Reviews<\/secondary-title><\/titles><dates><year>2010<\/year><\/dates><electronic-resource-num>10.1210\/er.2009-0027<\/electronic-resource-num><urls><related-urls><url>https:\/\/academic.oup.com\/edrv\/article-pdf\/31\/3\/364\/10335159\/edrv0364.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Pauline Morigny<\/author><author>J\u00e9r\u00e9mie Boucher<\/author><author>Peter Arner et al.<\/author><\/authors><\/contributors><titles><title>Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics<\/title><secondary-title>Nature Reviews Endocrinology<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1038\/s41574-021-00471-8<\/electronic-resource-num><urls><related-urls><url>https:\/\/push-zb.helmholtz-muenchen.de\/frontdoor.php?source_opus=61477<\/url><\/related-urls><\/urls><\/record>\n<\/records><\/xml>\n"

"\n\nMolGod<\/database>MOL-GOD<\/source-app>1<\/rec-number>17<\/ref-type>et al.<\/author><\/authors><\/contributors>Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><electronic-resource-num>10.1200\/jco.2012.44.8738<\/electronic-resource-num><urls><related-urls><url>https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2012.44.8738?role=tab<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1016\/j.expneurol.2007.11.001<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/2323600<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Acetyl-l-carnitine deficiency in patients with major depressive disorder.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1073\/pnas.1801609115<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.pnas.org\/content\/pnas\/115\/34\/8627.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2006<\/year><\/dates><electronic-resource-num>10.1016\/j.neulet.2005.12.013<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/1805703<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Ferreira GC<\/author><author>McKenna MC<\/author><\/authors><\/contributors><titles><title>L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.<\/title><secondary-title>Neurochemical research<\/secondary-title><\/titles><dates><year>2017<\/year><\/dates><electronic-resource-num>10.1007\/s11064-017-2288-7<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2002<\/year><\/dates><electronic-resource-num>10.1073\/pnas.261708898<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/122286<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1998<\/year><\/dates><electronic-resource-num>10.1073\/pnas.95.16.9562<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/21378<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2005<\/year><\/dates><electronic-resource-num>10.2337\/diacare.28.1.89<\/electronic-resource-num><urls><related-urls><url>https:\/\/diabetesjournals.org\/care\/article-pdf\/28\/1\/89\/646192\/zdc00105000089.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2004<\/year><\/dates><electronic-resource-num>10.1196\/annals.1320.003<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1016\/j.pain.2007.06.001<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/2689385<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Long-term acetyl-L-carnitine treatment in Alzheimer's disease.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1991<\/year><\/dates><electronic-resource-num>10.1212\/wnl.41.11.1726<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2003<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2003<\/year><\/dates><electronic-resource-num>10.1097\/00004850-200303000-00001<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2005<\/year><\/dates><electronic-resource-num>10.1016\/j.ejca.2005.04.028<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Involvement of PI3K\/PKG\/ERK1\/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2007<\/year><\/dates><electronic-resource-num>10.1016\/j.freeradbiomed.2006.11.006<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/1808543<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Zanelli SA<\/author><author>Solenski NJ<\/author><author>Rosenthal RE et al.<\/author><\/authors><\/contributors><titles><title>Mechanisms of ischemic neuroprotection by acetyl-L-carnitine.<\/title><secondary-title>Annals of the New York Academy of Sciences<\/secondary-title><\/titles><dates><year>2005<\/year><\/dates><electronic-resource-num>10.1196\/annals.1344.013<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fangfang Liu<\/author><author>Jingyu Chen<\/author><author>Kai Li et al.<\/author><\/authors><\/contributors><titles><title>Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches<\/title><secondary-title>Molecular Cancer<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1186\/s12943-024-02046-3<\/electronic-resource-num><urls><related-urls><url>https:\/\/molecular-cancer.biomedcentral.com\/counter\/pdf\/10.1186\/s12943-024-02046-3<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Acetyl-L-carnitine and \u03b1-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.1016\/j.pbb.2011.09.002<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Mary\u2010Elizabeth Patti<\/author><author>Silvia Corvera<\/author><\/authors><\/contributors><titles><title>The Role of Mitochondria in the Pathogenesis of Type 2 Diabetes<\/title><secondary-title>Endocrine Reviews<\/secondary-title><\/titles><dates><year>2010<\/year><\/dates><electronic-resource-num>10.1210\/er.2009-0027<\/electronic-resource-num><urls><related-urls><url>https:\/\/academic.oup.com\/edrv\/article-pdf\/31\/3\/364\/10335159\/edrv0364.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Pauline Morigny<\/author><author>J\u00e9r\u00e9mie Boucher<\/author><author>Peter Arner et al.<\/author><\/authors><\/contributors><titles><title>Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics<\/title><secondary-title>Nature Reviews Endocrinology<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1038\/s41574-021-00471-8<\/electronic-resource-num><urls><related-urls><url>https:\/\/push-zb.helmholtz-muenchen.de\/frontdoor.php?source_opus=61477<\/url><\/related-urls><\/urls><\/record>\n<\/records><\/xml>\n"